National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 71436-71437 [2019-27856]
Download as PDF
<![CDATA[
71436
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 19, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27859 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: March 2, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20817.
Contact Person: Anna Ghambaryan, M.D.,
Ph.D. Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2120, MSC 6902, Bethesda, MD
20892, 301–443–4032, anna.ghambaryan@
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical, Treatment and
Health Services Research Review
Subcommittee.
Date: March 12, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
Extramural Project Review Branch, National
Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700B
Rockledge Drive, Room 2114, Bethesda, MD
20892, (301) 451–2067, srinivar@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
December 19, 2019
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27861 Filed 12–26–19; 8:45 am]
[FR Doc. 2019–27857 Filed 12–26–19; 8:45 am]
Dated: December 19, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; R21 Mechanism for TimeSensitive Research Opportunities in
Environmental Health Sciences.
Date: January 15, 2020.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Sciences, Keystone Building, 530
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Laura A., Thomas,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709, 919–541–2824, laura.thomas@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pulmonary Vascular Disease Remodeling
Review.
Date: February 12, 2020.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Shelley S Sehnert, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7206, Bethesda, MD 20892–7924, 301–435–
0303, ssehnert@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Cardiovascular-Renal Outcomes in Pregnant
Women and Offspring.
Date: February 13, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Blvd., Bethesda, MD 20714.
E:\FR\FM\27DEN1.SGM
27DEN1
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
Contact Person: Melissa E Nagelin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7202, Bethesda, MD 20892, 301–435–0297,
nagelinmh2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Maximizing the Scientific Value of the
NHLBI Biorepository: Scientific
Opportunities for Exploratory Research.
Date: February 20, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Division of
Extramural Activities, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Rockville, MD 20892, zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Circadian Patterns of Gene Expression
Associated with Disease.
Date: February 28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Division of
Extramural Activities, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Rockville, MD 20892, zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27856 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(D) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Science
Advisory Board for Biosecurity.
The meeting will be open to the
public, with attendance limited to space
available. The meeting will also be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Individuals planning to attend in person
may preregister online at: https://
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
osp.od.nih.gov/biotechnology/nationalscience-advisory-board-for-biosecuritynsabb/. Preregistration will close at
12:00 noon Eastern Time (ET) on
January 17, 2020. Individuals in
attendance may also register onsite on
the day of the meeting. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: January 23–24, 2020.
Time: January 23, 2020, 12:30 p.m. to 5:00
p.m. (ET).
Agenda: The National Science Advisory
Board for Biosecurity will discuss: (1)
Considerations regarding security and public
transparency when sharing information about
research involving enhanced potential
pandemic pathogens; (2) other business of
the Board; and (3) a charge to the committee
will be presented.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: January 24, 2020, 9:00 a.m. (ET) to
Adjournment.
Agenda: The National Science Advisory
Board for Biosecurity will discuss: (1)
Considerations regarding security and public
transparency when sharing information about
research involving enhanced potential
pandemic pathogens; and (2) other business
of the Board.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Shayla Beckham,
Management Program Analyst, Office of
Science Policy, National Institutes of Health,
6705 Rockledge Drive, Suite 750, Bethesda,
MD 20892–9606, 301–496–9838,
shayla.beckham@nih.gov.
Any interested person may file written
comments by forwarding the statement to the
Contact Person listed on this notice.
Additional information about the meeting,
including an agenda, will be posted at:
https://osp.od.nih.gov/biotechnology/
national-science-advisory-board-forbiosecurity-nsabb/ when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: December 19, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27862 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
71437
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel
Transition to Independence SEP, March
10, 2020, 10:30 a.m. to 5:00 p.m.,
National Cancer Institute Shady Grove,
9609 Medical Center Drive, Room
7W602, Rockville, MD 20850
(Telephone Conference Call) which was
published in the Federal Register on
December 16, 2019, 84 FR 68465.
This meeting notice is amended to
correct the meeting name from National
Cancer Institute Special Emphasis Panel
Transition to Independence SEP to
National Cancer Institute Initial Review
Group Transition to Independence. The
meeting is closed to the public.
Dated: December 19, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27854 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Clinical Trials
Review Committee.
Date: February 27–28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn, Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Keary A. Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Pages 71436-71437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27856]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Pulmonary Vascular Disease Remodeling
Review.
Date: February 12, 2020.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Shelley S Sehnert, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7206, Bethesda, MD
20892-7924, 301-435-0303, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Cardiovascular-Renal Outcomes in Pregnant
Women and Offspring.
Date: February 13, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda,
MD 20714.
[[Page 71437]]
Contact Person: Melissa E Nagelin, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD
20892, 301-435-0297, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Maximizing the Scientific Value of the NHLBI
Biorepository: Scientific Opportunities for Exploratory Research.
Date: February 20, 2020.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Division of Extramural Activities, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive, Rockville, MD 20892,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Circadian Patterns of Gene Expression
Associated with Disease.
Date: February 28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Division of Extramural Activities, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive, Rockville, MD 20892,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: December 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27856 Filed 12-26-19; 8:45 am]
BILLING CODE 4140-01-P
